Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85
Phase 1
Completed
- Conditions
- Healthy VolunteerDry Age-related Macular Degeneration
- Interventions
- First Posted Date
- 2022-12-28
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- RBP4 Pty Ltd
- Target Recruit Count
- 15
- Registration Number
- NCT05667688
- Locations
- ๐ฆ๐บ
Nucleus Network, Melbourne, Australia
This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease
- First Posted Date
- 2022-03-04
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- RBP4 Pty Ltd
- Target Recruit Count
- 13
- Registration Number
- NCT05266014
- Locations
- ๐ฆ๐บ
Sydney Children's Hospitals Network, Westmead, New South Wales, Australia
๐ฆ๐บLions Eye Institute, Perth, Western Australia, Australia
๐จ๐ณNational Taiwan University Hospital, Taipei, Taiwan
Safety and Tolerability Study of LBS-008 in Healthy Adult Subjects After Single and Multiple Doses
- First Posted Date
- 2018-11-08
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- RBP4 Pty Ltd
- Target Recruit Count
- 71
- Registration Number
- NCT03735810
- Locations
- ๐ฆ๐บ
Linear Clinical Research, Perth, Australia
ยฉ Copyright 2025. All Rights Reserved by MedPath